Eltrombopag, low-dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia.
| Image |  |
|---|---|
| Description | scientific article published on 21 December 2017 |
| Author/s |
author: Cesar Homero Gutiérrez-Aguirre Perla Colunga-Pedraza David Gómez-Almaguer |
| Publication date | December 21, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |